Recent studies have found that the tumor frontier region (Stroma AReactive Invasion Front Areas, SARIFA) in gastric cancer is associated with the abnormal expression of lipid metabolism-related genes (including FABP2, FABP4)[48]. The gene discussed is FABP2; the disease is neoplasm.